Dr. K talks about Provider Education as a means to addressing early on-set cancers
Dr. K talks about using Innovation to Determine Risk
DR. K discusses the rise in early-onset cancers in young adults.
Financial toxicity - Prevention and Innovation for a Healthier Tomorrow - Milken Institute Global Conference 2024
Across the world, health systems are trying to improve care for their populations in an era of rising costs. As the cost increases prove unsustainable, leaders have been calling for prevention-focused strategies as well as more innovation in health delivery systems, creative financing, broader use of the latest technology, and value-based care that leads to improved patient outcomes. Join us for a discussion with health sector leaders to understand what this means for the future of health and how prevention and innovation can shape tomorrow.
Moderator
Esther Krofah, Executive Vice President, MI Health, Milken Institute
Speakers
Robert Bradway, Chairman and CEO, Amgen Inc.
David Feinberg, Chairman, Oracle Health
Karen Knudsen, CEO, American Cancer Society, Inc.; American Cancer Society Cancer Action Network
Meena Seshamani, Deputy Administrator and Director of Center for Medicare, Centers for Medicare & Medicaid Services
During SXSW 2024, City of Hope's president of health innovation and policy Harlan Levine, M.D., discussed the critical need for expanding access to optimal cancer care with Clifford Hudis (American Society of Clinical Oncology — ASCO), Karen Knudsen (American Cancer Society) and Aaron Strout (Real Chemistry).
Bob Cusack (Editor in Chief, The Hill) discusses the mission to end cancer with Dr. Clifford Hudis (CEO, American Society of Clincial Oncology), Dr. Karen Knudsen (CEO, American Cancer Society & American Cancer Society Cancer Action Network), and Stephen Ubl (President & CEO, PhRMA)
Dr. Karen E. Knudsen discusses Cancer Advocacy & Research Innovation
Dr. Karen Knudsen from the American Cancer Society, Dr. Danielle Carnival from the Cancer Moonshot team, and Othman Laraki from Color Health talked about how enabling early detection is the single most effective strategy for addressing cancer.
Cancer Moonshot Colorectal Cancer Forum
Colorectal Cancer Screening Guidelines
In a panel discussion this week, five leaders in oncology proposed an action plan for tackling cancer health disparities and enhancing health equity.
American Cancer Society CEO Karen E. Knudsen, PhD, MBA delivers the 2022 ASCO Genitourinary Cancers Symposium keynote lecture.
Presentation - CU Cancer Center
Karen Knudsen, PhD Executive Vice President of Oncology Services Jefferson Health
Reporting from the 2021 Genitourinary Cancers Symposium, Karen Knudsen comments on results from CRPC studies looking at molecular determinants associated with long term response to apalutamide in the SPARTAN study, and the final results from the ACIS study testing the addition of apalutamide to abiraterone and prednisone in metastatic disease.
She also gives an overview of the final results from the TITAN study testing apalutamide in metastatic castration-sensitive setting receiving ADT.